Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexeo Therapeutics, Inc. (LXEO) Change in Accured Expenses (2022 - 2023)

Lexeo Therapeutics' Change in Accured Expenses history spans 2 years, with the latest figure at -$2.1 million for Q4 2023.

  • For Q4 2023, Change in Accured Expenses fell 133.48% year-over-year to -$2.1 million; the TTM value through Dec 2023 reached $2.1 million, changed N/A, while the annual FY2024 figure was $3.4 million, 61.02% up from the prior year.
  • Change in Accured Expenses for Q4 2023 was -$2.1 million at Lexeo Therapeutics, down from $4.8 million in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $4.8 million in Q3 2023 and bottomed at -$2.1 million in Q4 2023.